The health care sector has declined by 0.18% in 2025. This is better than the S&P 500’s drop of 6.06%. The Health Care Select Sector SPDR Fund (XLV) is graphed below. Looking within the sector is ...

Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which ...

ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology 1, today announced that it has entered a ...

Here's how this healthcare leader could slowly make investors richer. Abbott Laboratories' healthcare business spans ...

Abbott Laboratories' $21 billion acquisition of Exact Sciences is fueling optimism that a long deal drought in health care is finally breaking — a potentially good sign for Illinois' health and ...

Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking one of the biggest offerings this year.

This morning med tech giant Abbott announced a new deal with chronic care management company Omada Health that will integrate Abbott’s FreeStyle Libre continuous glucose monitor (CGM) with Omada's ...

Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data ...

ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology 1, today announced that it has entered a ...